Published in Breast J on July 01, 1998
Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1980) 4.04
A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol (2001) 3.53
A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol (2000) 3.50
ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol (2000) 1.94
Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res (1997) 1.92
Completion pneumonectomy: current indications, complications, and results. J Thorac Cardiovasc Surg (2001) 1.88
Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol (1999) 1.88
Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol (2011) 1.84
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1993) 1.80
Detailed structural characterization of succinoglycan, the major exopolysaccharide of Rhizobium meliloti Rm1021. J Bacteriol (1994) 1.76
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol (2005) 1.72
Vascular smooth muscle cell dysfunction in patients with migraine. Neurology (2009) 1.71
Differential fluorescence induction reveals Streptococcus pneumoniae loci regulated by competence stimulatory peptide. Mol Microbiol (2001) 1.70
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1994) 1.69
Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus. Infect Immun (1999) 1.68
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol (1998) 1.64
Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. AIDS (2001) 1.64
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study. J Natl Cancer Inst (2001) 1.63
Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood (1994) 1.58
The xanthogranulomatous process. Xanthogranulomatous inflammation. Pathol Res Pract (1988) 1.55
Growth hormone and the heart. Endocr Rev (1994) 1.53
Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis. Clin Infect Dis (2001) 1.52
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol (1999) 1.47
Analysis of human herpesvirus type 8 infection in AIDS-related and AIDS-unrelated primary central nervous system lymphoma. J Infect Dis (1997) 1.47
Biological screening of Nigella damascena for antimicrobial and molluscicidal activities. Phytother Res (2004) 1.47
Metastasizing dermal squamomelanocytic tumour: more evidences. J Eur Acad Dermatol Venereol (2011) 1.46
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol (2014) 1.45
Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein. J Virol (1987) 1.43
Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J (1997) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Bone scan had no role in the staging of 765 consecutive operable T(1-2)N(0-1) breast cancer patients without skeletal symptoms. Ann Oncol (2001) 1.41
Occupation and soft-tissue sarcoma in northeastern Italy. Cancer Causes Control (1992) 1.41
Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res (1998) 1.40
Expression of natural killer antigens in a subset of 'non-T, non-B lymphoma/leukaemia with histiocytic features'. Br J Haematol (1990) 1.39
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy. Ann Oncol (2006) 1.38
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS (1989) 1.38
Surgical treatment of hydatid disease of the liver. A 20-year experience. Arch Surg (1991) 1.37
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (1999) 1.36
Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin Cancer Res (1997) 1.36
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther (2003) 1.35
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
An aspartate residue of the Yersinia pseudotuberculosis invasin protein that is critical for integrin binding. EMBO J (1995) 1.29
Phosphorylation of threonine in the proline-rich carboxy-terminal region of simian virus 40 large T antigen. J Virol (1981) 1.29
Purified polyoma virus medium T antigen has tyrosine-specific protein kinase activity but no significant phosphatidylinositol kinase activity. Mol Cell Biol (1986) 1.27
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev (2000) 1.26
Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol (2000) 1.26
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health (1982) 1.24
Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis (1994) 1.24
The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype. J Immunol (1985) 1.24
Composition and antimicrobial properties of essential oils of four Mediterranean Lamiaceae. J Ethnopharmacol (1993) 1.23
Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia (1998) 1.23
Dietary factors and non-Hodgkin's lymphoma: a case-control study in the northeastern part of Italy. Nutr Cancer (1989) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer (2006) 1.20
Anomalous dystroglycan in carcinoma cell lines. FEBS Lett (2000) 1.20
rho is not essential for viability or virulence in Staphylococcus aureus. Antimicrob Agents Chemother (2001) 1.19
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol (1995) 1.19
A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology (1997) 1.18
Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res (2001) 1.18
Regulation of dihydrodipicolinate synthase and aspartate kinase in Bacillus subtilis. J Bacteriol (1975) 1.18
Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ (1996) 1.17
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients. Oncogene (2006) 1.17
Penile Mondors' disease: an underestimated pathology. Br J Urol (1996) 1.17
Y-TZP ceramics for artificial joint replacements. Biomaterials (1998) 1.17
Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer (1997) 1.16
Decline of infant and child mortality rates in rural Senegal over a 37-year period (1963-1999). Int J Epidemiol (2001) 1.16
Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol (2008) 1.15
Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. Am J Pathol (1998) 1.15
Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol (1998) 1.14
Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood (1997) 1.13
Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. Am J Pathol (1999) 1.13
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infection. Microbiology (2001) 1.13
Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys (2001) 1.12
New Y-TZP powders for medical grade zirconia. J Mater Sci Mater Med (1997) 1.11
Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis (1996) 1.11
Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene (1995) 1.11
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res (1999) 1.10
Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab (2000) 1.10
Efficacy of an essential oil of Eugenia caryophyllata against Psoroptes cuniculi. Exp Parasitol (2006) 1.10
Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys (1998) 1.09
Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab (1993) 1.09
Calcium transport and contractile activity in dissociated mammalian heart cells. Am J Physiol (1979) 1.09
Preoperative chemotherapy is essential for conservative surgery of Askin tumors. J Thorac Cardiovasc Surg (2003) 1.09
Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia (1999) 1.08
Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS (1996) 1.08